Active Compounds
What Scientific Research Says About Pau d'Arco
Important disclaimer
This article is for educational purposes only and is not medical advice. These statements have not been evaluated by the Food and Drug Administration. Pau d'Arco is not intended to diagnose, treat, cure, or prevent any disease. We summarize published research and traditional use — this is not a recommendation to use Pau d'Arco for any specific condition. Always consult a qualified healthcare professional before starting a new supplement, especially alongside an existing medical condition or medication.
Pau d'Arco (Tabebuia impetiginosa) has been a subject of real scientific investigation since the 1960s, after centuries as a traditional Amazonian remedy. Most of that research is laboratory (in vitro) and animal (in vivo) work; human clinical trials remain limited. This article surveys the breadth of that research honestly — organized by what kind of evidence backs each claim, not by which claim sounds most impressive.
The Pharmacological Profile
Reviews in Molecules describe over 100 active chemicals in the bark — quinones, flavonoids, benzoic acids — with the naphthoquinones lapachol and beta-lapachone as the most studied. Lapachol drew NCI attention in the late 1960s for antitumor activity in rats; beta-lapachone has been the focus of more recent research into selective apoptosis in cancer cell lines. See Lapachol and Beta-Lapachone for a deeper look at these two compounds specifically, and Pau d'Arco and Cancer for the fuller cancer-research picture.
Antimicrobial and Antiviral Activity
Lab research reports Pau d'Arco extracts active against Candida albicans, with studied ability to disrupt microbial biofilms and inhibit efflux pumps (mechanisms microbes use to resist treatment). Separate research in Antiviral Research has looked at activity against influenza and herpes simplex viruses. All of this is laboratory-level evidence.
Source: Journal of Ethnopharmacology; Antiviral Research
Anti-Inflammatory and Chondroprotective Effects
Water extracts of Pau d'Arco reduced colitis symptoms in animal models by lowering pro-inflammatory cytokines (IL-1β, TNF-α) via the NF-κB and AP-1 pathways. Separate research on cartilage protection in osteoarthritis models found reduced activity of cartilage-degrading enzymes (MMP2, MMP9). See Pau d'Arco and Inflammation for the full breakdown.
Source: BMC Complementary and Alternative Medicine (2017); Mediators of Inflammation
Antioxidant Power and Mitochondrial Research
A 2014 study in the Journal of Toxicological Sciences found Pau d'Arco increased expression of Nrf2-target genes (part of the body's internal antioxidant defense system) in an animal intestinal model. Separately, beta-lapachone has been studied as a catalyst for NAD+, a coenzyme tied to mitochondrial function — research that's generated interest but remains at an early, mechanistic stage.
What Research Says About Cancer
Traditional use of Pau d'Arco for cancer in South America is extensive; human clinical evidence remains early-stage.
Laboratory studies have reported Pau d'Arco extracts inhibiting proliferation of several human tumor cell lines (breast, lung, liver) in vitro. Separately, pharmaceutical researchers developed synthetic derivatives of Pau d'Arco-related chemistry — including napabucasin (BBI-608) — which was studied in Phase III human trials for advanced solid tumors. Napabucasin is a distinct, purified synthetic compound, not Pau d'Arco tea, and its trial outcomes don't transfer to a claim about drinking tea.
Source: Expert Opinion on Therapeutic Patents (2017)
Memorial Sloan Kettering's public research summaries note that while anticancer activity is well established in lab settings, more rigorous human trials are needed to establish safe, effective dosing in people. Early Phase I trials on pure lapachol in the 1970s produced side effects (nausea, anti-vitamin K activity) at the doses required — see Pau d'Arco and Cancer for the full history and current research picture.
Proper Preparation for Maximum Extraction
The quinoids in Pau d'Arco aren't highly water-soluble in a simple steep. Extracting them requires the decoction method: adding bark to boiling water, simmering at a low boil for 20–25 minutes, then straining. See our full brewing guide and Taheebo Wellness Tea for the method we use.
Precautions and Considerations
- Pregnancy: isolated lapachol has shown abortifacient properties in animal studies; Pau d'Arco is generally not recommended during pregnancy.
- Anticoagulation: potential anti-vitamin K activity means those on blood thinners should consult a physician.
- Dosage: large single doses beyond traditional amounts may cause GI upset.
- Quality and species: only the inner bark of Tabebuia impetiginosa/avellanedae contains the studied compound profile — see our sourcing guide.
Where This Leaves Us
The research base on Pau d'Arco is real, and it's broad — antimicrobial, anti-inflammatory, antioxidant, and cancer-cell mechanism research all exist. Nearly all of it sits at the lab or animal tier, with human clinical trials still the exception rather than the rule. That's not a reason to dismiss the research; it's a reason to be precise about what it does and doesn't show.
References
- 1.Frontiers in Pharmacology (2025): "β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1"
- 2.Scientific Reports (2025): "Lapachol inhibits proliferation and migration of bladder tumor cells"
- 3.MDPI Molecules (2024): "Anticancer Potential and Safety Profile of β-Lapachone In Vitro"
- 4.PubMed (2016): "β-Lapachone Inhibits Lung Metastasis of Colorectal Cancer"
- 5.ScienceDirect (2005): "Down-regulation of COX-2 and telomerase activity by β-lapachone in human prostate carcinoma cells"
- 6.PMC (2023): "Safety and tolerability of Pau d'Arco for primary dysmenorrhea"